These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25033622)

  • 1. Insurers brace for high-cost Sovaldi.
    Demko P; Dickson V
    Mod Healthc; 2014 May; 44(18):9. PubMed ID: 25033622
    [No Abstract]   [Full Text] [Related]  

  • 2. Why Sovaldi shouldn't cost $84,000.
    Goozner M
    Mod Healthc; 2014 May; 44(18):26. PubMed ID: 25033627
    [No Abstract]   [Full Text] [Related]  

  • 3. Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.
    Canary LA; Klevens RM; Holmberg SD
    Ann Intern Med; 2015 Aug; 163(3):226-8. PubMed ID: 26121095
    [No Abstract]   [Full Text] [Related]  

  • 4. Early Patterns of Sofosbuvir Utilization by State Medicaid Programs.
    Liao JM; Fischer MA
    N Engl J Med; 2015 Sep; 373(13):1279-81. PubMed ID: 26398092
    [No Abstract]   [Full Text] [Related]  

  • 5. Sovaldi ushers in wave of costly hepatitis C drugs.
    Manag Care; 2014 Jan; 23(1):51. PubMed ID: 24765752
    [No Abstract]   [Full Text] [Related]  

  • 6. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
    Einecke D
    MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
    [No Abstract]   [Full Text] [Related]  

  • 7. Sofosbuvir (Sovaldi) for chronic hepatitis C.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):5-6. PubMed ID: 24457562
    [No Abstract]   [Full Text] [Related]  

  • 8. Dare to refuse the exorbitant price of Sovaldi!
    Prescrire Int; 2014 Nov; 23(154):278. PubMed ID: 25954802
    [No Abstract]   [Full Text] [Related]  

  • 9. US health insurers say Gilead hepatitis C drug too costly.
    Clin Infect Dis; 2014 Jul; 59(2):i-ii. PubMed ID: 25105185
    [No Abstract]   [Full Text] [Related]  

  • 10. Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.
    Barua S; Greenwald R; Grebely J; Dore GJ; Swan T; Taylor LE
    Ann Intern Med; 2015 Aug; 163(3):215-23. PubMed ID: 26120969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sovaldi dilemma likely to get worse.
    Carroll J
    Manag Care; 2014 Sep; 23(9):9, 12. PubMed ID: 25282860
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C drug maker puts profit ahead of patients, US Senate report charges.
    McCarthy M
    BMJ; 2015 Dec; 351():h6573. PubMed ID: 26635239
    [No Abstract]   [Full Text] [Related]  

  • 13. New expensive treatments for hepatitis C infection.
    Brennan T; Shrank W
    JAMA; 2014 Aug; 312(6):593-4. PubMed ID: 25038617
    [No Abstract]   [Full Text] [Related]  

  • 14. Special report: cost-effectiveness studies of new hepatitis C treatments.
    Mark DH;
    Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
    [No Abstract]   [Full Text] [Related]  

  • 15. The uses and abuses of cost-effectiveness analysis.
    Goozner M
    Mod Healthc; 2014 Aug; 44(32):26. PubMed ID: 25318245
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on "no to greed".
    Hunt DP
    South Med J; 2015 Jan; 108(1):65-6. PubMed ID: 25580762
    [No Abstract]   [Full Text] [Related]  

  • 17. Sovaldi makes blockbuster history, ignites drug pricing unrest.
    Senior M
    Nat Biotechnol; 2014 Jun; 32(6):501-2. PubMed ID: 24911474
    [No Abstract]   [Full Text] [Related]  

  • 18. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 19. China rejects patent on hepatitis C drug sofosbuvir.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3429. PubMed ID: 26105994
    [No Abstract]   [Full Text] [Related]  

  • 20. Payers consider waiting out budget-busting hepatitis C drug.
    Carroll J
    Manag Care; 2014 May; 23(5):7, 9. PubMed ID: 25016845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.